Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD
- Address
- lock Available on a paid plan
Nervous System Diseases and Psychiatry Research
At the Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD in Sofia, clinical trials focus on disorders affecting the brain and behavior, especially Alzheimer’s disease, psychosis, agitation, and related cognitive symptoms. These studies are designed to test new treatment options and better understand how to ease difficult neuropsychiatric symptoms.
- Research on Alzheimer’s disease psychosis and Lewy body dementia psychosis
- Studies targeting agitation in dementia-related conditions
- Evaluation of new therapies for hallucinations and delusions
The site contributes to efforts aimed at improving symptom control and long-term care for people living with complex neuropsychiatric disorders.
Depression and Mood Disorders
A major part of the research portfolio centers on major depressive disorder, including forms with anhedonia and insomnia symptoms. These trials are exploring new ways to reduce depressive symptoms, prevent relapse, and assess the safety and usefulness of add-on treatments.
- Studies in major depressive disorder and treatment-resistant depression
- Research on depression with anhedonia or sleep-related symptoms
- Trials evaluating both symptom improvement and long-term treatment benefit
This work reflects a strong interest in finding better options for people whose depression has not responded well to standard care.
Schizophrenia and Psychosis Treatment Studies
The site also supports trials in schizophrenia, with a focus on improving control of persistent symptoms and evaluating how well new adjunctive therapies work. These studies are intended to strengthen treatment effectiveness while also examining tolerability over time.
- Research on inadequately controlled schizophrenia
- Evaluation of add-on therapies for psychotic symptoms
- Assessment of treatment effectiveness and longer-term safety
Such studies help expand options for patients who need more effective symptom management in everyday clinical practice.
Anxiety and Behavioral Health
Another important area of research involves generalized anxiety disorder, where trials are examining potential therapies for people who continue to experience symptoms despite current treatment. The goal is to improve anxiety relief and support better day-to-day functioning.
- Clinical research in generalized anxiety disorder
- Studies of treatments for ongoing anxiety symptoms
- Work focused on improving response when standard therapy is not enough
These studies broaden the site’s psychiatry portfolio by addressing both emotional symptoms and the behavioral impact of anxiety.
Cognitive Disorders and Early Alzheimer’s Disease
Trials at this Sofia site also include people with mild cognitive impairment and mild dementia related to Alzheimer’s disease. This research aims to understand whether new treatments can help preserve cognition and daily function while addressing the broader progression of memory-related illness.
- Studies in mild cognitive impairment and early dementia
- Research on maintaining cognition and everyday function
- Evaluation of treatment approaches for early-stage Alzheimer’s-related decline
By including both cognitive and psychiatric conditions, the Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD supports a broad view of brain health research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Intra-Cellular Therapies Inc.4active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Intra-Cellular Therapies Inc.4trials
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD
lock Showing 1 of 25 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP) | Acadia Pharmaceuticals Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acp-204 Tartrate | 4 | Unknown | 2024-07-02 | 2026-05-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
